Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018.

Top 5 companies occupied 40% of the market.

By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest.

Market Analysis and Insights: Global Recombinant Proteins Market
The research report studies the Recombinant Proteins market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Recombinant Proteins market size is projected to reach US$ 1062 million by 2026, from US$ 665.5 million in 2020, at a CAGR of 8.1% during 2021-2026.

Global Recombinant Proteins Scope and Segment
The global Recombinant Proteins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

Segment by Type, the Recombinant Proteins market is segmented into
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.

Segment by Application, the Recombinant Proteins market is segmented into
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.

Global Recombinant Proteins market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The major vendors covered:
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation